DANISH BIO – DANSK BIOTEK organizes four major plenary meetings for our members throughout the year to increase our members' knowledge regarding specific biotech topics and to facilitate networking. The events usually take place in February, May, September and November.

We also organize approximately four "saloon" meetings annually. They are small, intimate, "meet the expert" meetings with typically 6-20 participants advocating more in-depth discussion and knowledge-sharing on specific themes.

News

Y-mAbs Announces Initiation of Submission of Omburtamab Rolling Biologics License Application to the FDA 30 June 2020

Y-mAbs Therapeutics, Inc., a late-stage clinical biopharmaceutical company focused on the develop... Read more

Free book download for our members: Assembled Chaos: Accelerate your medical research career while changing the future of medicine… 30 June 2020

As you probably realise consortia are becoming an increasingly common way to conduct medical research... Read more

Dansk Standard: Invitation to participation in development of the future Biotech standards 10 June 2020

Are you interested in being part of developing the future Biotech standards ?Read more

Y-mAbs Announces U.S. FDA Acceptance of Biologics License Application for Danyelza™ (naxitamab) for the Treatment of Neuroblastoma for Priority Review 08 June 2020

Y-mAbs Therapeutics, Inc., a late-stage clinical biopharmaceutical company focused on the develop... Read more

Y-mAbs Announces Data to be Presented at 2020 ASCO Annual Meeting 13 May 2020

Y-mAbs Therapeutics, Inc., a late-stage clinical biopharmaceutical company focused on the development... Read more

Y-mAbs Announces First Quarter 2020 Financial Results and Recent Corporate Developments 07 May 2020

Y-mAbs Therapeutics, Inc., a late-stage clinical biopharmaceutical company focused on the development... Read more

Y-mAbs to Announce First Quarter 2020 Financial and Operating Results on May 7, 2020 30 April 2020

Y-mAbs Therapeutics, Inc. today announced that it will report its financial results for the first quarter... Read more

Y-mAbs Announces Appointment of Laura J. Hamill to its Board of Directors 27 April 2020

Y-mAbs Therapeutics, Inc., a late-stage clinical biopharmaceutical company focused on the development... Read more

Article: Trial Subject GDPR Consent – A Do or a Don’t? 17 April 2020

This article written by Jan Bjerrum Bach, Attorney-at-law, Jusmedico Law Firm / BioLawEurope will give... Read more

Copyright 2020 DANISH BIO – DANSK BIOTEK. All rights reserved.

created by: Mastafu Design